Volvaltrate B is primarily studied for its potential sedative and anxiolytic effects, making it of interest in the development of central nervous system depressants. It has been investigated for use in managing anxiety, insomnia, and other stress-related disorders due to its interaction with GABAergic neurotransmission. Research suggests it may enhance the effect of gamma-aminobutyric acid (GABA), a key inhibitory neurotransmitter, which helps reduce neuronal excitability. This mechanism supports its traditional use in herbal sedatives, particularly in preparations derived from Valerian root. Ongoing studies explore its role as a natural alternative to synthetic benzodiazepines, with efforts focused on improving bioavailability and minimizing side effects.